Cargando…
Latest updates on cellular and molecular biomarkers of gliomas
Gliomas are the most common central nervous system malignancies, compromising almost 80% of all brain tumors and is associated with significant mortality. The classification of gliomas has shifted from basic histological perspective to one that is based on molecular biomarkers. Treatment of this typ...
Autores principales: | Bou Zerdan, Maroun, Atoui, Ali, Hijazi, Ali, Basbous, Lynn, Abou Zeidane, Reine, Alame, Saada M., Assi, Hazem I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678906/ https://www.ncbi.nlm.nih.gov/pubmed/36425564 http://dx.doi.org/10.3389/fonc.2022.1030366 |
Ejemplares similares
-
COVID-19 and lung cancer: update on the latest screening, diagnosis,
management and challenges
por: Moubarak, Simon, et al.
Publicado: (2022) -
Mechanisms of Immunotoxicity: Stressors and Evaluators
por: Bou Zerdan, Maroun, et al.
Publicado: (2021) -
Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023) -
Clinical Significance of Breast Cancer Molecular Subtypes and Ki67 Expression as a Predictive Value for Pathological Complete Response following Neoadjuvant Chemotherapy: Experience from a Tertiary Care Center in Lebanon
por: Atoui, Ali, et al.
Publicado: (2022) -
Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)